Grantham, Mayo, Van Otterloo & Co (GMO)
COV

Grantham, Mayo, Van Otterloo & Co (GMO)’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,819,037
Closed -$1B – 468
2014
Q4 		$1B Sell
9,819,037
-3,161,975
-24% -$303M 2.7% 11
2014
Q3 		$1.12B Buy
12,981,012
+10,204,524
+368% +$904M 2.97% 10
2014
Q2 		$250M Buy
2,776,488
+672,900
+32% +$50.3M 0.68% 38
2014
Q1 		$155M Buy
2,103,588
+879,497
+72% +$61.3M 0.4% 49
2013
Q4 		$83.4M Buy
1,224,091
+659,786
+117% +$42.9M 0.2% 72
2013
Q3 		$34.4M Buy
564,305
+29,325
+5% +$1.79M 0.09% 97
2013
Q2 		$29.8M Buy
+534,980
New +$30.9M 0.08% 101

Grantham, Mayo, Van Otterloo & Co (GMO)'s COV Position: Q1 2015 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 9,819,037 shares — an estimated $1B sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $1.12B in Q3 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,819,037 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $1B.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $1.12B in Q3 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2015, filed 14 May 2015.